Related references
Note: Only part of the references are listed.Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program
Amichai Perlman et al.
ISRAEL JOURNAL OF HEALTH POLICY RESEARCH (2019)
Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment
Emmeline Tran et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens
Javier Trujillo-Santos et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Utilization and prescribing patterns of direct oral anticoagulants
Maegan M. Whitworth et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2017)
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy
Megan E. Barra et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Non-Vitamin K Anticoagulant Dose Selection
Daniel M. Witt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
Antonio Gomez-Outes et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2014)
Apixaban for Extended Treatment of Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Share Paper
